LGP2 deficiency decreases intracellular dsDNA signaling. by Darja Pollpeter (353259)

<i>C</i>. <i>sinensis</i> induced prominently expressed TLR2 in mouse BECs. by Yuru Wang (846969)

Subjects:

CD4+ cell depletion decreases fibrosis and improves lymphatic function. A. by Jamie C. Zampell (298073)

G0S2 stability is decreased in mice lacking ATGL. by Bradlee L. Heckmann (2818306)

HAI-2 deficiency leads to decreased proliferation of intestinal epithelium. by Roman Szabo (138655)

Loss of Cntnap2 decreases specifically stabilization of new spines. by Amos Gdalyahu (3213810)

“…<p><b>a.</b> From left to right: Chronic imaging through a cranial window of L5 pyramidal neuron. …”

Cumulative effects and geographic distribution of mCHG-decreasing alleles. by Eriko Sasaki (501178)

“…Chr1:4035022 (<i>JMJ26</i>) was excluded from the analysis of CMT2-targeted transposons as it has no effect. Chr5:2355910 was used for <i>MSI1</i>. …”

Effect of SNX5 S226 phosphorylation on macropinocytosis. by Nao Itai (5954666)

Subjects:

Distinct effects on calcium channel activation of <i>CACNA1I</i> disease-associated amino acid substitutions A398E/V and M1425V/I. by Yousra El Ghaleb (22075892)

Subjects:

Berberine inhibits 4-AP-induced glutamate release from rat cerebrocortical nerve terminals; this effect is due to a decrease in vesicular exocytosis. by Tzu-Yu Lin (423761)

“…<p>Glutamate release (+Ca²⁺; A) and Ca²⁺-independent glutamate release (-Ca²⁺; C) was measured under control conditions or in the presence of 10 µM berberine added 10 min prior to the addition of 4-AP. …”

PKCε activation induces aggrecan gene expression, decreases ADAMTS5, and detection of ADAMTS-5-depended cleavage of ECM aggrecan through upregulation of hsa-miR-377 expression. by Emmanouella Tsirimonaki (490707)

“…<p>(<b>A</b>) RT-PCR detected the relative expression of ACAN, MKI67, ADAMTS5 after treatment of NP cells with 1 μM ψεRACK (or vehicle) for indicated times and revealed that time-dependent activation of PKCε significantly increased the mRNA expression for aggrecan, while in an opposing manner decreased ADAMTS5; mRNA levels of the proliferation marker Ki67 became barely detectable after 8 hours of PKCε activation. …”

Increased BBB disruption, with a decrease in endothelial ZO-1, claudin-5 and occludin, avoided by GM6001. by Saran Feng (345936)

Vectorized siRNA TMPRSS2-ERG IV-SQ impaired tumour growth and restored differentiation <i>in vivo</i>. by Giorgia Urbinati (554921)

“…<p><b>a.</b> SCID mice (n = 5/group) bearing VCaP tumour xenografts were injected intravenously either with NaCl 0.9%, non-vectorized siRNA TMPRSS2-ERG IV, NPs siRNA control-SQ or NPs siRNA TMPRSS2-ERG IV-SQ twice per week during 6 weeks (1.8 mg/kg/mouse cumulative dose). …”

Ibuprofen and diclofenac decrease migration. by Verena Leidgens (815986)

IL-15 treatment results in decreased lipid deposition in 3T3-L1 mature adipocytes and IL-6 and KC production with increasing IL-15 treatment. by Nicole G. Barra (317230)

Ibuprofen and diclofenac decrease proliferation. by Verena Leidgens (815986)

“…<p>Proliferation was analyzed using crystal violet staining and results were verified via the CyQuant Direct Cell Proliferation assay in HTZ-349. (A) Starting at 72 h, all ibuprofen concentrations (0.5, 1, 2 mM) resulted in significant reduction of HTZ-349 proliferation (compared to non-treated Ctrl, 95% CI, p < 0.05). 2 mM ibuprofen caused significant proliferation inhibition at 24 h (0.01 > p ≤ 0.001) and 48 h (p < 0.0001). …”

MSCs decrease oligodendrocyte death. by Justin D. Glenn (800439)

Forbush Decrease Catalog at MESSENGER by Emma Davies (12046748)

“…Finally, the number of steps observed (1, 2, or C for complex), the quality rating (1--4, from highest to lowest) and the ratio between the 1st and 2nd slope (if present) are given.…”

Real-world mepolizumab treatment in patients with severe asthma decreased exacerbations, oral corticosteroid use, and healthcare resource utilization and costs over 4 years: a retr... by Wendy C. Moore (10682686)

“…</p> <p>Among 189 eligible patients, mean asthma exacerbation rate (AER) declined progressively from baseline during follow-up: AER decreased by 53.8% at Year 1 and 73.8% by Year 4 (<i>p</i> < 0.001). …”

Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…<p>In the recurrence group, mean outpatient visits (± standard deviation) decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”